COVID-19 Vaccine Makers' Booster Shots Aim At A Moving Target: Coronavirus Variants
In the future, different circumstances will likely determine which vaccine or booster a person receives, based on their antibodies — and which variant is common in their region.
by Bill Chappell
Feb 25, 2021
3 minutes

The U.S. is still ramping up its vaccination program, hoping to finally clamp down on the COVID-19 pandemic. But even as vaccine doses are being rolled out, their makers are exploring several strategies to bolster them, hoping to protect people against worrying new variants that have sprung up in recent months, from South Africa to the U.K.
The companies that have FDA-authorized vaccines are currently working on the problem, out of concern that mutations in SARS-CoV-2 could make the virus more difficult to control. Several strains seem to spread more easily than older forms of
Vous lisez un aperçu, inscrivez-vous pour en lire plus.
Commencez votre mois gratuit